Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $56.71 for the day, down -0.51% from the previous closing price of $57.00. In other words, the price has decreased by -$0.51 from its previous closing price. On the day, 1.67 million shares were traded. VKTX stock price reached its highest trading level at $57.21 during the session, while it also had its lowest trading level at $55.05.
Ratios:
Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 37.69 and its Current Ratio is at 37.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on June 27, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On May 16, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $115 to $116.
Oppenheimer reiterated its Outperform rating for the stock on March 26, 2024, while the target price for the stock was revised from $116 to $138.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 14 ’24 when SINGLETON J MATTHEW sold 20,786 shares for $57.53 per share. The transaction valued at 1,195,736 led to the insider holds 9,500 shares of the business.
SINGLETON J MATTHEW bought 20,786 shares of VKTX for $1,195,735 on Aug 14 ’24. On Jul 30 ’24, another insider, ZANTE GREG, who serves as the Chief Financial Officer of the company, sold 16,136 shares for $57.15 each. As a result, the insider received 922,212 and left with 187,052 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 6283240960 and an Enterprise Value of 5342089728.
Stock Price History:
Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is 4.52%, while the 200-Day Moving Average is calculated to be 22.29%.
Shares Statistics:
VKTX traded an average of 3.86M shares per day over the past three months and 2433340 shares per day over the past ten days. A total of 110.80M shares are outstanding, with a floating share count of 103.53M. Insiders hold about 7.12% of the company’s shares, while institutions hold 74.09% stake in the company. Shares short for VKTX as of 1722384000 were 16862235 with a Short Ratio of 4.36, compared to 1719532800 on 16825918. Therefore, it implies a Short% of Shares Outstanding of 16862235 and a Short% of Float of 20.48.
